|
|
REGIONAL ACTIVITIES: October 2025 – April 2026
Complimentary Grand Rounds Regional SeriesCME/MOC-AccreditedAbout the Program What’s included:
Upcoming Sessions Optimizing Treatment for Patients
with Relapsed/Refractory Chronic Lymphocytic Leukemia Oct 2025 – Mar 2026
Optimizing the Use of Novel Therapies
for Patients with Diffuse Large B-Cell Lymphoma Jan 2026 – Apr 2026
Additional topics will be announced throughout 2026.
|